Jiangsu Recbio Technology Co Ltd HKEX:2179:
NEW DRUG APPLICATION FOR REC610 SHINGLES VACCINE ACCEPTED
APPLICATION ACCEPTED BY CENTER FOR DRUG EVALUATION, NMPA
Jiangsu Recbio Technology Says New Drug Application For REC610 Shingles Vaccine Accepted By NMPA
Earlier from Jiangsu Recbio Technology Co., Ltd. Class H
- Jiangsu Recbio Technology Says Liu Yong Resigned As Chair
- Jiangsu Recbio Technology Says Li Bu Resigned As Executive Director